BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
ECBK
ECB Bancorp, Inc.
ECBK has the edge over BAC overall, supported by stronger valuation and stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ECBK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ECBK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ECBK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
ECBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $20.45 | — |
| Cheap | 18x | $26.66 | +30% |
| Fair | 25x | $37.12 | +82% |
| Expensive | 39x | $58.32 | +185% |
Historical ranges are pointers, not guarantees.
ECBK has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
ECBK Forward outlook
There aren't enough analyst estimates for ECBK to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ECBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.49 | +86% |
| Q2 2026 | $1.38 | +112% |
| Q1 2026 | $1.16 | +104% |
| Q4 2025 | $0.94 | +96% |
| Q3 2025 | $0.80 | +111% |
| Q2 2025 | $0.65 | +63% |
| Q1 2025 | $0.57 | +19% |
| Q4 2024 | $0.48 | -7.7% |
ECBK earned $1.49 per share over the past year, up 86% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ECBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.1M | +26% |
| Q2 2026 | $10.3M | +29% |
| Q1 2026 | $10.2M | +47% |
| Q4 2025 | $9.5M | +34% |
| Q3 2025 | $8.8M | +33% |
| Q2 2025 | $8M | +27% |
| Q1 2025 | $6.9M | +11% |
| Q4 2024 | $7.1M | +15% |
ECBK has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 42% | +4.6 points |
| Q2 2026 | 43% | +19 points |
| Q1 2026 | 42% | +17 points |
| Q4 2025 | 37% | +9.4 points |
| Q3 2025 | 37% | +14 points |
| Q2 2025 | 24% | +7 points |
| Q1 2025 | 25% | +12 points |
| Q4 2024 | 27% | +10 points |
ECBK has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ECBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.4M | -13% |
| Q2 2026 | $11.8M | +538% |
| Q1 2026 | $2.8M | +$3.5M |
| Q4 2025 | $3.9M | -14% |
| Q3 2025 | $4M | +359% |
| Q2 2025 | $1.8M | +37% |
| Q1 2025 | -$649K | -$200K |
| Q4 2024 | $4.5M | +77% |
ECBK has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ECBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ECBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +56.5K shares |
| 1 year | +1.4% | +119K shares |
| 3 years | -1.1% | -93.4K shares |
ECBK has 8M diluted shares, up 1.4% from a year ago, despite $2M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $188,000 |
| Q2 2026 | $675,000 |
| Q1 2026 | $350,000 |
| Q4 2025 | $513,000 |
| Q3 2025 | $2M |
| Q2 2025 | $1.5M |
| Q1 2025 | $673,000 |
| Q4 2024 | $902,000 |
ECBK spent $2M buying back its own shares over the past year, down 65% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over ECBK on leverage, with a lower net debt burden relative to earnings.
ECBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 16.3x | High |
| Q2 2026 | 17.9x | High |
| Q1 2026 | 19.5x | High |
| Q4 2025 | 26.3x | High |
| Q3 2025 | 28.1x | High |
| Q2 2025 | 34.9x | High |
| Q1 2025 | 35.0x | High |
| Q4 2024 | 40.2x | High |
ECBK's net debt is about 16 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ECBK.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ECBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.2 | Neutral |
| Stochastic | 56.6 | Neutral |
ECBK's weekly RSI is 52 (neutral) and its Stochastic is 57 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over ECBK on valuation relative to its sector.
ECBK PE vs Financial Services Sector
| Metric | ECBK | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 5.4% above |
| PE % | 0 | 58 | 58 pts below |
ECBK is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ECBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.9 | 1.9% below |
| 20 week MA | $20.7 | 1.1% below |
| 50 week MA | $18.9 | 8% above |
| 100 week MA | $17.3 | 18% above |
| 200 week MA | $15.2 | 35% above |
ECBK has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
ECBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $14.0 | $16.1 | +15% |
| 2023 | $16.1 | $12.6 | -22% |
| 2024 | $12.6 | $14.9 | +19% |
| 2025 | $14.9 | $17.3 | +16% |
| 2026 YTD | $17.3 | $20.5 | +18% |
ECBK has the edge over BAC on returns for 2026, with the stronger performance.